KeyBank National Association
SGMO

KeyBank National Association’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

KeyBank National Association’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-33,614
Closed -$570K – 1029
2018
Q3 		$570K Sell
33,614
-5,419
-14% -$82.4K ﹤0.01% 737
2018
Q2 		$554K Buy
39,033
+13,921
+55% +$231K ﹤0.01% 714
2018
Q1 		$477K Sell
25,112
-12,697
-34% -$271K ﹤0.01% 754
2017
Q4 		$620K Sell
37,809
-3,718
-9% -$55.3K ﹤0.01% 689
2017
Q3 		$623K Sell
41,527
-43,630
-51% -$482K ﹤0.01% 715
2017
Q2 		$749K Sell
85,157
-50,090
-37% -$321K ﹤0.01% 686
2017
Q1 		$703K Hold
135,247
– – ﹤0.01% 712
2016
Q4 		$413K Buy
135,247
+40,854
+43% +$149K ﹤0.01% 868
2016
Q3 		$437K Buy
94,393
+13,148
+16% +$66.9K ﹤0.01% 865
2016
Q2 		$470K Buy
81,245
+9,215
+13% +$58.7K ﹤0.01% 795
2016
Q1 		$436K Buy
72,030
+5,465
+8% +$32.8K ﹤0.01% 820
2015
Q4 		$608K Buy
66,565
+3,881
+6% +$29.9K ﹤0.01% 716
2015
Q3 		$354K Buy
62,684
+24,598
+65% +$203K ﹤0.01% 902
2015
Q2 		$422K Buy
38,086
+12,394
+48% +$160K ﹤0.01% 888
2015
Q1 		$403K Sell
25,692
-1,826
-7% -$28.3K ﹤0.01% 920
2014
Q4 		$419K Buy
27,518
+2,260
+9% +$27.4K ﹤0.01% 913
2014
Q3 		$272K Sell
25,258
-4,443
-15% -$58K ﹤0.01% 1078
2014
Q2 		$454K Buy
29,701
+1,436
+5% +$20.7K ﹤0.01% 934
2014
Q1 		$511K Sell
28,265
-7,169
-20% -$138K ﹤0.01% 893
2013
Q4 		$492K Buy
35,434
+4,168
+13% +$48K ﹤0.01% 915
2013
Q3 		$328K Sell
31,266
-2,835
-8% -$28.2K ﹤0.01% 1015
2013
Q2 		$266K Buy
+34,101
New +$298K ﹤0.01% 1162

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

KeyBank National Association's SGMO Position: Q4 2018 in Review

KeyBank National Association sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2018, closing a stake of 33,614 shares — an estimated $570K sold.

KeyBank National Association first reported a position in SGMO in Q2 2013 and held it in 22 quarters. The position peaked at $749K in Q2 2017. 197 funds tracked by Wall St. Rank hold SGMO as of Q4 2018.

  • KeyBank National Association reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2018 after selling out during the quarter.
  • KeyBank National Association sold 33,614 SANGAMO THERAPEUTICS INC shares in Q4 2018, an estimated $570K.
  • KeyBank National Association first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 22 quarters.
  • KeyBank National Association's SANGAMO THERAPEUTICS INC position peaked at $749K in Q2 2017.
  • 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2018.

Based on KeyBank National Association's 13F filing for Q4 2018, filed 30 Jan 2019.